Therapeutic efficacy and safety of chaperonin 10 in patients with rheumatoid arthritis: a double-blind randomised trial (Q80207327)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16950363%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Therapeutic efficacy and safety of chaperonin 10 in patients with rheumatoid arthritis: a double-blind randomised trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16950363%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

Daina Vanags

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16950363%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Bronwyn Williams

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16950363%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Barbara Johnson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16950363%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Stephen Hall

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16950363%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Peter Nash

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16950363%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Andrew Taylor

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16950363%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Julissa Weiss

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16950363%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Dennis Feeney

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16950363%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

language of work or name

English

0 references

publication date

1 September 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16950363%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16950363%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

368

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16950363%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

9538

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16950363%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

855-863

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16950363%20AND%20SRC:MED&resulttype=core&format=json

Unfolding the role of chaperones and chaperonins in human disease

29 December 2019

uses

randomized experiment

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969210-6

7 January 2021

Heat shock protein 10 inhibits lipopolysaccharide-induced inflammatory mediator production

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969210-6

7 January 2021

Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969210-6

7 January 2021

Limiting inflammatory responses during activation of innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969210-6

7 January 2021

Negative regulation of toll-like receptor-mediated immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969210-6

7 January 2021

Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969210-6

7 January 2021

The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969210-6

7 January 2021

Joint inflammation and cytokine inhibition in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969210-6

7 January 2021

Development of anti-TNF therapy for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969210-6

7 January 2021

Role of cytokines in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969210-6

7 January 2021

Pro-inflammatory cytokines in rheumatoid arthritis: pathogenetic and therapeutic aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969210-6

7 January 2021

The safety of infliximab, combined with background treatments, among patients with rheumatoid arthritis and various comorbidities: a large, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969210-6

7 January 2021

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969210-6

7 January 2021

A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969210-6

7 January 2021

Outstanding issues in use of disease-modifying agents in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969210-6

7 January 2021

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969210-6

7 January 2021

The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969210-6

7 January 2021

Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969210-6

7 January 2021

Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969210-6

7 January 2021

Anti-interleukin-1 and anti-tumor necrosis factor-alpha synergistically inhibit adjuvant arthritis in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969210-6

7 January 2021

TLR signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969210-6

7 January 2021

p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969210-6

7 January 2021

10.1016/S0140-6736(06)69210-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16950363%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference